Basal cell carcinomas, squamous carcinomas and prostate carcinoma cells with high metastatic potential contain increased amounts of Dsg2 [52]–[54] whereas in certain types of gastric carcinomas Dsg2 is reduced or abnormally distributed [55], [56]. The gene discussed is DSG2; the disease is prostate carcinoma.